Patenting in the public interest
’ Administration of insulin patents by the University of Toronto
Bibliographic Data
| ID | 14800652 |
|---|---|
| Authors | Maurice Cassier (0000-0003-3908-8073, corresponding author), Christiane Sinding |
| Year | 2008 |
| Volume | 24 |
| Issue | 2 |
| Pages | 153-171 |
| Publication date | 2008-06-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | History and Technology (JOURNAL) |
| Journal identifiers | ISSN: 0734-1512 • E-ISSN: 1477-2620 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/07341510701810948 |
| OpenAlex | W1982042585 |
| Language | EN |
| Citations received | 14 |
| References cited | 10 |
Whereas the norms of the academic world and medical ethics prohibited academics and doctors from applying for patents on medical inventions, the University of Toronto decided in 1922 to file a patent application on the discovery of insulin, covering both the therapeutic substance and the isolation and purification processes developed by the inventors. The University extended its patent to 25 countries in North America, Europe, Latin America, Australia, India and Japan. An Insulin Committee was set up to ‘administer the patents in the public interest’. Toronto University's intention was to use its industrial property rights in a particular way: to control the standards and quality of a potentially dangerous drug, and to prevent the emergence of a monopoly that might limit the drug's accessibility to patients. The administration of insulin patents ‘in the public interest’ was a highly controversial subject during the inter‐war years. On the one hand there were those who advocated regulation of the quality of drugs via patents and, on the other hand, those who opposed the idea of the University of Toronto receiving royalties to finance its medical research
Business · Economics · Intellectual property · Latin Americans · Library science · Market economy · Monopoly · Political science · Public interest · Sociology · Historical Medical Research and Treatments · History of Medical Practice · Law · Medical History and Innovations · Public Administration
Technology Commercialization as University Mission
A Thing Patented is a Thing Divulged
Fármacos y patentes
A responsibility to commercialize? Tracing academic researchers’ evolving engagement with the commercialization of biomedical research
The Reformulation Regime in Drug Discovery
The commercial roots of the genomic commons
‘Our project, your problem?’ A case study of the WHO’s mRNA technology transfer programme in South Africa
Are You Open
Out of the Ivory Tower
Commercializing science
Patents and public health in France. Pharmaceutical patent law in‐the‐making at the patent office between the two world wars
Pharmaceutical patenting and the transformation of American medical ethics
Who Owns What? Private Ownership and the Public Interest in Recombinant DNA Technology in the 1970s
The Patent and the Paper
| Unique citing works | 14 |
|---|---|
| Citations per year | 0,78 |
| Citation span | 2008 - 2025 (18) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 13 |